The group has a modern production base of more than 600 acres, a research and development building of more than 6,000 square meters, a 100,000-level GMP workshop standard, an annual production capacity of more than 5,000 tons of small molecule peptide raw materials and products, and more than 50 kinds of independent products. It has a number of core technology patents in the peptide industry: its own single-substance extraction technology, full-substance chain extraction technology, its own enzymatic hydrolysis technology, and more than 300 scientific research achievements such as the core technology for the extraction of small molecule peptides from herbs.

    Under the strategic sector of health and nutrition, we strictly abide by international production standards, and have international production system certifications such as HACCP hazard analysis and critical control point system, ISO22000 food safety management system, and FSSC 22000. We focus on technological innovation, developing innovative raw materials to meet market demands for solutions that provide effective, completely safe and high-quality products.

    Over the years, Taiai Peptide has conducted in-depth cooperation with many scientific research institutions, universities and hospitals, as well as Ren Yandong, Zhang Li, Lu Tao, Yang Yanjun and other well-known experts and scholars in the industry. In 2021, we will cooperate with the School of Food Science of Jiangnan University to jointly establish a joint research and development center for peptide substances. Through the cooperation and complementation of research and development technology, we will continuously improve the transformation of Taiai peptide scientific research results.